Bard Associates’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$154K Sell
2022
Q2
$207K Hold
2022
Q1
$243K Buy
2021
Q4
$240K Buy
2021
Q3
$346K Buy
2021
Q2
$429K Buy
2021
Q1
$417K Buy